Pulse Biosciences (PLSE) Return on Equity (2021 - 2025)

Historic Return on Equity for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to 0.76%.

  • Pulse Biosciences' Return on Equity rose 1100.0% to 0.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.67% for FY2024, which is 13300.0% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Return on Equity is 0.76%, which was up 1100.0% from 0.61% recorded in Q2 2025.
  • Pulse Biosciences' Return on Equity's 5-year high stood at 7.9% during Q1 2023, with a 5-year trough of 29.69% in Q4 2022.
  • Its 5-year average for Return on Equity is 2.38%, with a median of 0.87% in 2024.
  • Per our database at Business Quant, Pulse Biosciences' Return on Equity crashed by -290400bps in 2022 and then skyrocketed by 288200bps in 2023.
  • Over the past 5 years, Pulse Biosciences' Return on Equity (Quarter) stood at 0.65% in 2021, then crashed by -4486bps to 29.69% in 2022, then soared by 97bps to 0.87% in 2023, then surged by 37bps to 0.55% in 2024, then tumbled by -37bps to 0.76% in 2025.
  • Its Return on Equity was 0.76% in Q3 2025, compared to 0.61% in Q2 2025 and 0.52% in Q1 2025.